Home/ Supplements/ Vitamin K/ Multi+ Vita-Lea Gold Without Vitamin K

Multi+ Vita-Lea Gold Without Vitamin K

product on market Tablet or Pill Shaklee Safety: 99/100
99/100

This product looks safe

  • Folate: 668mg is 668.0× the Tolerable Upper Intake Level (1.0mg)
  • 63% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains essential vitamins A, C, D3, and E, which are supported by strong evidence for maintaining immune function and cellular health. These nutrients act as antioxidants and support bone density and vision. The overall ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 668mg is 668.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Multi+ Vita-Lea Gold Without Vitamin K
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
63%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Vitamin A
1500 mcg (167% DV)
Vitamin C
120 mg (133% DV)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
40 mg (267% DV)
2.7× RDA — within safe limits 179 studies (A:3, B:90)
2.25 mg (188% DV)
1.9× RDA — within safe limits 76 studies (A:0, B:33)
2.55 mg (196% DV)
2.0× RDA — within safe limits 13 studies (A:0, B:1)
30 mg (188% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
4 mg (235% DV)
3.1× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
668 mcg DFE (167% DV)
Exceeds UL by 668.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
24 mcg (1000% DV)
10.0× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (1000% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
15 mg (300% DV)
3.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
450 mg (35% DV)
350 mg (28% DV)
Within RDA (0.5× RDA) 13 studies (A:0, B:3)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
225 mg (54% DV)
Within RDA (0.5× RDA) 316 studies (A:8, B:159)
22.5 mg (205% DV)
2.0× RDA — within safe limits 263 studies (A:6, B:134)
70 mcg (127% DV)
1.3× RDA — within safe limits 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
2.3 mg (100% DV)
Within RDA (1.0× RDA) 9 studies — no high-quality reviews
120 mcg (343% DV)
3.4× RDA — above typical dose 199 studies (A:1, B:55)
75 mcg (167% DV)
1.7× RDA — within safe limits 3 studies — no high-quality reviews
Sodium
5 mg (1% DV)
Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Nickel
5 mcg
Tin
10 mcg
20 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
2 mg
Market median: 108.0mg (8 products) 9 studies (A:0, B:4)

Other Ingredients

Microcrystalline Cellulose Hydroxypropylmethylcellulose Croscarmellose Sodium Spirulina Riboflavin Soy Lecithin Inositol Choline Bitartrate Alfalfa powder Grapefruit Bioflavonoid Hesperidin Lemon Bioflavonoid Orange Bioflavonoid Rice Bran, Powder Rose Hips powder Acerola Extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 2 tablets daily.

Warnings & Precautions

Seal under cap for your protection.

Manufactured in a facility that may also process tree nuts, milk, egg, soy, wheat, shellfish, and fish.

Formulation Notes

Vitality guaranteed

Backed by 100 years of nutritional innovation and packed with all the essential minerals plus 100% DV or more of every vitamin, with 400% DV of vitamin B12, 1,000 IU of vitamin D3, extra calcium, and N-acetylcysteine to protect against free radical damage.

Features our patented Bioactivated Absorption System. +Supports heart, brain, eyes, bones

Gluten free

The perfect multi for heart, brain, eye, and bone health

No artificial flavors, sweeteners, or preservatives added.

Star-K (Kosher)

Additional Information

Based on 7 clinical studies

Star-K (Kosher)

U.S. Patent No(s). 6,465,013; 6,852,335

U.S. Patent No(s). 6,465,013; 6,852,335

Metadata

Product Details

DSLD Entry Date2022-02-23
Product TypeOther Combinations
FormTablet or Pill
BrandShaklee
DSLD ID261168
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K 100 mcg
Vitamin World · Tablet or Pill
100
Vitamin K2
Higher Nature · Tablet or Pill
100
Vitamin K-1
The Vitamin Shoppe · Tablet or Pill
100
Vitamin K1 100 mcg
The Vitamin Shoppe · Tablet or Pill
100
Vitamin K1 100 mcg
Country Life · Tablet or Pill
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Shaklee View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.